Skip to main content
. 2014 Jan 30;119(1):10–18. doi: 10.3109/03009734.2013.851748

Figure 3.

Figure 3.

Angiotensinogen (AGT) in diabetic-Wistar and SHR rats treated (▪) or not (□) with 2-chloroadenosine (CADO). A: plasma AGT concentration (µg/mL; n = 6–7); B: urinary AGT excretion (ngAGT/mg Creat; n = 9–11). Results expressed as Mean±SEM. *p <0.05 versus corresponding diabetic group.

Results expressed as mean ± SEM; *p < 0.05 versus corresponding diabetic group.